Literature DB >> 19171191

Calcium and ATP handling in human NADH:ubiquinone oxidoreductase deficiency.

Federica Valsecchi1, John J Esseling, Werner J H Koopman, Peter H G M Willems.   

Abstract

Proper cell functioning requires precise coordination between mitochondrial ATP production and local energy demand. Ionic calcium (Ca(2+)) plays a central role in this coupling because it activates mitochondrial oxidative phosphorylation (OXPHOS) during hormonal and electrical cell stimulation. To determine how mitochondrial dysfunction affects cytosolic and mitochondrial Ca(2+)/ATP handling, we performed life-cell quantification of these parameters in fibroblast cell lines derived from healthy subjects and patients with isolated deficiency of the first OXPHOS complex (CI). In resting patient cells, CI deficiency was associated with a normal mitochondrial ([ATP](m)) and cytosolic ([ATP](c)) ATP concentration, a normal cytosolic Ca(2+) concentration ([Ca(2+)](c)), but a reduced Ca(2+) content of the endoplasmic reticulum (ER). Furthermore, cellular NAD(P)H levels were increased, mitochondrial membrane potential was slightly depolarized, reactive oxygen species (ROS) levels were elevated and mitochondrial shape was altered. Upon stimulation with bradykinin (Bk), the peak increases in [Ca(2+)](c), mitochondrial Ca(2+) concentration ([Ca(2+)](m)), [ATP](c) and [ATP](m) were reduced in patient cells. In agreement with these results, ATP-dependent Ca(2+) removal from the cytosol was slower. Here, we review the interconnection between cytosolic, endoplasmic reticular and mitochondrial Ca(2+) and ATP handling, and summarize our findings in patient fibroblasts in an integrative model.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19171191     DOI: 10.1016/j.bbadis.2009.01.001

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  9 in total

Review 1.  Mitochondrial Oxidative Phosphorylation System (OXPHOS) Deficits in Schizophrenia: Possible Interactions with Cellular Processes.

Authors:  Oded Bergman; Dorit Ben-Shachar
Journal:  Can J Psychiatry       Date:  2016-08       Impact factor: 4.356

2.  Mice lacking TR4 nuclear receptor develop mitochondrial myopathy with deficiency in complex I.

Authors:  Su Liu; Yi-Fen Lee; Samuel Chou; Hideo Uno; Gonghui Li; Paul Brookes; Michael P Massett; Qiao Wu; Lu-Min Chen; Chawnshang Chang
Journal:  Mol Endocrinol       Date:  2011-05-26

3.  Mitochondrial calcium uniporter stabilization preserves energetic homeostasis during Complex I impairment.

Authors:  Enrique Balderas; David R Eberhardt; Sandra Lee; John M Pleinis; Salah Sommakia; Anthony M Balynas; Xue Yin; Mitchell C Parker; Colin T Maguire; Scott Cho; Marta W Szulik; Anna Bakhtina; Ryan D Bia; Marisa W Friederich; Timothy M Locke; Johan L K Van Hove; Stavros G Drakos; Yasemin Sancak; Martin Tristani-Firouzi; Sarah Franklin; Aylin R Rodan; Dipayan Chaudhuri
Journal:  Nat Commun       Date:  2022-05-19       Impact factor: 17.694

Review 4.  Cell-permeable protein therapy for complex I dysfunction.

Authors:  Salvatore Pepe; Robert M Mentzer; Roberta A Gottlieb
Journal:  J Bioenerg Biomembr       Date:  2014-07-09       Impact factor: 2.945

Review 5.  Mouse models for nuclear DNA-encoded mitochondrial complex I deficiency.

Authors:  Saskia Koene; Peter H G M Willems; Peggy Roestenberg; Werner J H Koopman; Jan A M Smeitink
Journal:  J Inherit Metab Dis       Date:  2010-01-27       Impact factor: 4.982

Review 6.  Mitochondria in lung diseases.

Authors:  Bharathi Aravamudan; Michael A Thompson; Christina M Pabelick; Y S Prakash
Journal:  Expert Rev Respir Med       Date:  2013-08-27       Impact factor: 3.772

7.  Altered Expression Ratio of Actin-Binding Gelsolin Isoforms Is a Novel Hallmark of Mitochondrial OXPHOS Dysfunction.

Authors:  Alberto García-Bartolomé; Ana Peñas; María Illescas; Verónica Bermejo; Sandra López-Calcerrada; Rafael Pérez-Pérez; Lorena Marín-Buera; Cristina Domínguez-González; Joaquín Arenas; Miguel A Martín; Cristina Ugalde
Journal:  Cells       Date:  2020-08-19       Impact factor: 6.600

8.  Mitochondrial complex I inhibition as a possible mechanism of chlorpyrifos induced neurotoxicity.

Authors:  Mohamed Salama; Doaa El-Morsy; Mohamed El-Gamal; Osama Shabka; Wael My Mohamed
Journal:  Ann Neurosci       Date:  2014-07

Review 9.  NDUFA12L mitochondrial complex-I assembly factor: Implications for taupathies.

Authors:  Mohamed Salama; Wael M Y Mohamed
Journal:  Appl Transl Genom       Date:  2015-06-18
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.